News
PLAINSBORO, NJ, USA I June 22, 2025 I Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk's phase 3 REDEFINE 1 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback